P73 protein in carcinogenesis and response to anti-tumor therapy
Vinogradskaia, G.R.
Voprosy Onkologii 59(2): 34-40
2013
ISSN/ISBN: 0507-3758 PMID: 23814847 Document Number: 663959
Document emailed within 1 workday
Related Documents
Fu, Q.; Zhang, W.; Meng, F.; Guo, R.; Yao, Z. 2002: Study on the anti-tumor efficacy induced by heat shock protein 70-peptide complexes derived from tumor cells Chinese Medical Sciences Journal 17(3): 153-156Rossowska, J.; Pajtasz-Piasecka, E.; Szyda, A.; Zietara, N.; Duś, D. 2007: Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response Folia Histochemica et Cytobiologica 45(4): 349-355
Szakal, A.K.; Hanna, M.G. 1974: Cell-mediated immune response of hamsters to alloantigen and tumor antigens of isologous and autochthonous origin during chemical carcinogenesis Cancer Research 34(1): 138-145
Juhl, P.; Thudium, C.S.; Gudmann, N.S.; Karsdal, M.A.; Bay-Jensen, A.-C.; Siebuhr, A.S. 2018: IL-6 receptor inhibition modulates type IIi collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study Clinical and Experimental Rheumatology 36(4): 568-574
Dobrowolski, J.W.; Tadeusiewicz, R. 1986: Current theories on tumor growth and carcinogenesis. I. Analysis of carcinogenesis from the point of view of information theory Ginekologia Polska 57(12): 771-777
Waalkes, M.P.; Rehm, S.; Riggs, C.W.; Bare, R.M.; Devor, D.E.; Poirier, L.A.; Wenk, M.L.; Henneman, J.R. 1989: Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site Cancer Research 49(15): 4282-4288
Lee, S.G.; Heo, D.S.; Yoon, S.J.; Jee, Y.S.; Kang, J.O.; Kim, K.; Kim, C.D.; Sung, M.W.; Kim, N.K. 2000: Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response Anticancer Research 20(4): 2681-2686
Iinuma, S.; Schomacker, K.T.; Wagnieres, G.; Rajadhyaksha, M.; Bamberg, M.; Momma, T.; Hasan, T. 1999: In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model Cancer Research 59(24): 6164-6170
Warren, P.; Song, W.; Holle, E.; Holmes, L.; Wei, Y.; Li, J.; Wagner, T.; Yu, X. 2002: Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice Anticancer Research 22(2a): 599-604
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945
Williams, R.T.; Carbonaro-Hall, D.A.; Hall, F.L. 1992: Co-purification of p34cdc2/p58cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/threonine protein kinase with a tumor-suppressor protein Oncogene 7(3): 423-432
Watanabe, M.A.; De Lucca, F.L. 1996: Anti-tumor effect of splenocytes treated with RNA from animals immunized with bovine myelin basic protein Cellular and Molecular Biology 42(2): 249-254
Qi, Y.; Moyana, T.; Chen, Y.; Xiang, J. 1996: Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau Human Antibodies and Hybridomas 7(1): 21-26
Tan, X.-h.; Wan, Y.-h. 2005: Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury Zhonghua Yi Xue Za Zhi 85(23): 1596-1600
Teng, L.-S.; Jin, K.-T.; Han, N.; Cao, J. 2010: Radiofrequency ablation, heat shock protein 70 and potential anti-tumor immunity in hepatic and pancreatic cancers: a minireview Hepatobiliary and Pancreatic Diseases International: Hbpd Int 9(4): 361-365
Sriram, S.; Carroll, L.; Fortin, S.; Cooper, S.; Ranges, G. 1988: In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis Journal of Immunology 141(2): 464-468
Meleshko, A.N.; Vashkevich, K.P.; Fomina, E.G.; Scheslenok, E.P.; Schkolina, T.V.; Sergeev, G.V. 2013: Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination Experimental Oncology 35(1): 8-14
Garcia-Porrua, C.; Gonzalez-Gay, M.A.; Quevedo, V. 2006: Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? Journal of Rheumatology 33(2): 433; Author Reply 433-4
Su, X.; Li, L.; Wang, P. 2012: Research progress of the anti-tumor effect of sonodynamic and photodynamic therapy Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 29(3): 583-587
Derbala, M.F.; Amer, A.M.; El Defrawi, I.E. 2006: Anti-HCV IgM as predictor of response to interferon therapy in schistosomal patients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(1): 44